Primary Synovial Sarcoma of Testis: a case report and review of literature.
Primary synovial sarcoma of testis is extremely rare neoplasm. We are going to describe a very rare presentation of primary synovial sarcoma originated from testis.
Presentation of case:
A 57year-old man presented with painless left testicular mass. Ultrasonography revealed a large testicular mass in the inguinal region; therefore, the patient underwent radical surgical excision of the tumor followed by adjuvant chemotherapy. One year after treatment, he was having a favorable life quality and no evidence of recurrence was documented.
Testicular Synovial sarcoma is a very rare and slow growing malignancy that must be considered in the differential diagnosis of testicular mass.
-Ferrari A, Sultan I, Huang TT, Rodriguez-Galindo C, Shehadeh A, Meazza C, Ness KK, Casanova M, Spunt SL. Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database.Pediatr Blood Cancer. 2011; 57: 943-949.
-Ferrari A, De Salvo GL, Dall'Igna P, Meazza C, De Leonardis F, Manzitti C, De Ioris MA, Casanova M, Carli M, Bisogno G. Salvage rates and prognostic factors after relapse in children and adolescents with initially localised synovial sarcoma. Eur J Cancer. 2012; 48: 3448-3455.
-Nesrine M, Sellami R, Doghri R, Rifi H, Raies H, Mezlini A. Testicular Synovial Sarcoma: A Case Report. Cancer Biol Med. 2012; 9: 274–276.
-Sharma S, Sharma A, Lobo G, Nayak M, Pradhan D, Samriti, Bindal S, Gogoi K, Katara R, Kini L, Mohanty SK. Pathol Res Pract. 2017; 213:868-871.
-Antman K, Crowley J, Balcerzak SP, Rivkin SE, Weiss GR, Elias A, Natale RB, Cooper RM, Barlogie B, Trump DL. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.J Clin Oncol. 1993; 11:1276-1285.
-Iwahashi N, , Deguchi Y, Horiuchi Y, Ino K, Furukawa K. Omental synovial sarcoma mimicking an ovarian alignancy: A case report. Mol Clin Oncol. 2017; 6: 688–690.
-Dallos M, Tap WD, D'Angelo SP. Current status of engineered T-cell therapy for synovial sarcoma. Immunotherapy. 2016 ;8:1073-1080.
- There are currently no refbacks.